Rene Ruckert
Bern, BE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
LONG-TERM EFFICACY AND SAFETY OF PHOTOBIOMODULATION IN DRY AGE-RELATED MACULAR DEGENERATION (LIGHTSITE III: 24-MONTH ANALYSIS).
Journal: Retina (Philadelphia, Pa.)
Published: March 06, 2026
Long-term Efficacy and Safety of Photobiomodulation in Dry Age-Related Macular Degeneration (LIGHTSITE III: 24-Month Analysis).
Journal: Retina (Philadelphia, Pa.)
Published: March 06, 2026
A Response to: Letter to the Editor Regarding "LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration".
Journal: Ophthalmology and therapy
Published: January 10, 2024
LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System.
Journal: Retina (Philadelphia, Pa.)
Published: November 16, 2023
Non-Invasive Treatment of Early Diabetic Macular Edema by Multiwavelength Photobiomodulation with the Valeda Light Delivery System.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: April 28, 2023
How the immune response to the structural proteins of SARS-CoV-2 affects the retinal vascular endothelial cells: an immune thrombotic and/or endotheliopathy process with in silico modeling.
Journal: Immunologic research
Published: April 14, 2023
Expression of key SARS-CoV-2 entry molecules in surgically obtained human retinal biopsies.
Journal: International ophthalmology
Published: September 26, 2022
LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration.
Journal: Ophthalmology and therapy
Published: August 22, 2022
A bioinformatic analysis: Previous allergen exposure may support anti- SARS-CoV-2 immune response.
Journal: Computational biology and chemistry
Published: June 07, 2021
Using bioinformatic protein sequence similarity to investigate if SARS CoV-2 infection could cause an ocular autoimmune inflammatory reactions?
Journal: Experimental eye research
Published: August 23, 2020
A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION.
Journal: Retina (Philadelphia, Pa.)
Published: August 13, 2019
Last Updated: 09/26/2026